INNOCAN PHARMA CORP (INNPF:OTCMKTS)
$1.62 0.04 (2.5316%)
Analysed INNOCAN PHARMA CORP (INNPF:OTCMKTS) News Sources
Innocan Pharma to Present at the 2025 ThinkEquity Conference
24-10-2025
yahoo.com
Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M
27-11-2025
yahoo.com
Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering
10-12-2025
yahoo.com
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
27-01-2026
yahoo.com
Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs
09-02-2026
yahoo.com
Innocan Pharma LPT-CBD is featured in Pain Medicine News
06-05-2026
yahoo.com
Valitic Surpasses 2 Million Trusted Customers, Marking a Major Milestone in Its Consumer Wellness Growth
29-07-2026
yahoo.com
Innocan Pharma Posts Strong Q1 2026 Results*, With Revenue Surging 29.7% to US$6.47M
27-05-2026
yahoo.com
What is the current price of INNOCAN PHARMA CORP (INNPF:OTCMKTS)?
The current price of INNOCAN PHARMA CORP (INNPF:OTCMKTS) is $1.62.
INNOCAN PHARMA CORP (INNPF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of INNOCAN PHARMA CORP (INNPF:OTCMKTS) since the previous trading day is $0.04.
INNOCAN PHARMA CORP (INNPF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of INNOCAN PHARMA CORP (INNPF:OTCMKTS) since the previous trading day is 2.5316%.
What is the most recent average sentiment score for INNOCAN PHARMA CORP (INNPF:OTCMKTS)?
The most recent average sentiment score for INNOCAN PHARMA CORP (INNPF:OTCMKTS) is 62 out of 100.
What is the most recent average sentiment for INNOCAN PHARMA CORP (INNPF:OTCMKTS)?
The most recent sentiment for INNOCAN PHARMA CORP (INNPF:OTCMKTS) is .
SEC-8K** Filing Available For INNOCAN PHARMA CORP (INNPF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.